实用肝脏病杂志 ›› 2026, Vol. 29 ›› Issue (4): 637-640.doi: 10.3969/j.issn.1672-5069.2026.04.040

• 胆石症 • 上一篇    

胆道镜取石联合腹腔镜左半肝切除术治疗复杂性肝内胆管结石患者疗效研究*

李洋, 时磊, 于彬, 于勇, 郭洪海   

  1. 061000 河北省沧州市中心医院胰脾腹膜肿瘤中心(李洋,时磊,于彬);东光县中医医院急诊科(于勇);河北医科大学第四医院外三科( 郭洪海)
  • 收稿日期:2026-03-10 出版日期:2026-07-10 发布日期:2026-07-20
  • 作者简介:李洋,男,37岁,医学硕士,主治医师。研究方向:主要从事肝胆胰脾常见病及腹膜肿瘤防治研究。E-mail:amberfish2009@163.com
  • 基金资助:
    *河北省卫健委医学科学研究计划项目(编号:20232113)

Choledochoscope stone removal during laparoscopic left hepatectomy in dealing with patients with sophisticated intrahepatic bile duct stones

Li Yang, Shi Lei, Yu Bin, et al   

  1. Department of Pancreatic, Spleen and Peritoneal Tumor Surgery, Central Hospital, Cangzhou 061000, Hebei Province, China
  • Received:2026-03-10 Online:2026-07-10 Published:2026-07-20

摘要: 目的 评估胆道镜取石联合左半肝切除术(LLH)治疗复杂性肝内胆管结石(sIHBDS)患者的疗效。方法 2022年4月~2023年12月我院诊治的100例sIHBDS患者,被分为两组,每组50例。对照组接受LLH治疗,观察组接受胆道镜取石联合LLH治疗。采用ELISA法检测血清C反应蛋白(CRP)水平,采用化学发光免疫分析法检测血清皮质醇(COR)和肾上腺素(EP)水平,使用流式细胞仪检测外周血NK细胞和淋巴细胞亚群。结果 在术后2个月,超声检查发现观察组肝内胆管结石清除率为92.0%,显著高于对照组的76.0%(P<0.05);在术后7 d,观察组白细胞计数、中性粒细胞百分比和血清CRP水平分别为(6.6±1.1)×109/L、(73.1±6.3)%和(13.2±2.2)mg/L,均显著低于对照组【分别为(7.7±1.1)×109/L、(77.9±6.9)%和(18.0±2.1)mg/L,P<0.05】;两组血清COR和EP水平比较差异无统计学意义(P>0.05);观察组血清TBIL、ALT和AST水平分别为(20.4±6.0)μmol/L、(73.9±20.2)U/L和(50.2±9.8)U/L,均显著低于对照组【分别为(27.0±8.1)μmol/L、(94.0±23.4)U/L和(51.3±10.9)U/L,P<0.05】;观察组外周血CD3+、CD4+和NK细胞百分比分别为(68.4±6.5)%、(41.1±5.0)%和(18.7±2.2)%,均显著高于对照组【分别为(62.1±6.0)%、(37.2±4.2)%和(15.5±2.1)%,P<0.05】,而CD8+细胞百分比为(20.3±3.2)%,显著低于对照组【(24.0±3.1)%,P<0.05】。结论 采取胆道镜取石联合LLH术治疗sIHBDS患者可提高结石清除率,改善肝功能和免疫功能指标,其远期疗效还有待进一步观察。

关键词: 肝内胆管结石, 胆道镜取石, 左半肝切除术, 治疗

Abstract: Objective This study was to investigate choledochoscope stone removal (CSR) during laparoscopic left hepatectomy (LLH) in dealing with patients with sophisticated intrahepatic bile duct stones (sIHBDS). Methods 100 patients with sIHBDS were encountered in our hospital between April 2022 and December 2023, and were randomly assigned to underwent LLH in control (n=50) or underwent CSR during LLH in observation (n=50). Serum C-reactive protein (CRP level was detected by ELISA, serum cortisol (COR) and epinephrine (EP) levels were measured by using chemiluminescence immunoassay, and peripheral blood lymphocyte subsets and natural killer cells were determined by FCA. Results Intrahepatic stone clearance rate in the observation group was 92.0%, much higher than 76.0%(P<0.05)in the control as confirmed by US two months after surgery; by end of seven days after operation, white blood cell count, percentage of neutrophils andserum CRP level in the observation group were (6.6±1.1)×109/L, (73.1±6.3)% and (13.2±2.2)mg/L, all much lower than [(7.7±1.1)×109/L, (77.9±6.9)% and (18.0±2.1)mg/L, respectively, P<0.05] in the control; there were no significantly differences as respect to serum COR and EP levels between the two groups (P>0.05); serum bilirubin, ALT and AST levels were (20.4±6.0)μmol/L, (73.9±20.2)U/L and (50.2±9.8)U/L, all much lower than [(27.0±8.1)μmol/L, (94.0±23.4)U/L and (51.3±10.9)U/L, respectively, P<0.05] in the control; percentages of peripheral blood CD3+, CD4+ and NK cells were (68.4±6.5)%, (41.1±5.0)% and (18.7±2.2)%, all significantly higher than [(62.1±6.0)%, (37.2±4.2)% and (15.5±2.1)%, P<0.05], while percentage of CD8+ cells was(20.3±3.2)%, significantly lower than [(24.0±3.1)%, P<0.05] in the control group. Conclusion Choledochoscopy-assisted LLH in patients with sIHBDS could improve stone removal, promote liver function test recovery and enhances immune functions, and the long-term efficacy needs further clinical observation.

Key words: Intrahepatic bile duct stones, Choledochoscope stone removal, Laparoscopic left hepatectomy, Therapy